TNFR2 balancing Tregs – Tribute to Alexander Calder & Banksy 2023 – Andreas Beilhack Immunotherapy Program Würzburg

TNFR2 agonists balance Tregs in inflammation and cancer, tribute to Alexander Calder and Banksy, Andreas Beilhack and Harald Wajant laboratories, Immunotherapy Program Würzburg, Transregio 221 GvH-GvL, patents on TNFR2 targeting reagents, invention, development of novel classes of biologicals for immunotherapy, immunology research Germany

TNFR2 agonists balance Tregs in cancer, infection, neurodegenerative diseases, and inflammation. Beilhack and Wajant labs, Würzburg 2023